Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Clinical trial NCT00977574 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00977574
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Recurrent Malignant Uterine Corpus Neoplasm Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage

Start date: 2009-09-14
Primary completion: 2015-01-31
Enrollment: 349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.